loadpatents
name:-0.099793910980225
name:-0.036004066467285
name:-0.040211915969849
DUCHATEAU; Philippe Patent Filings

DUCHATEAU; Philippe

Patent Applications and Registrations

Patent applications and USPTO patent grants for DUCHATEAU; Philippe.The latest application filed is for "cellular immunotherapy for repetitive administration".

Company Profile
37.39.98
  • DUCHATEAU; Philippe - DRAVEIL FR
  • DUCHATEAU; Philippe - Dravell FR
  • Duchateau; Philippe - Paris FR
  • Duchateau; Philippe - Gargan N/A FR
  • Duchateau; Philippe - Livry Gargan N/A FR
  • Duchateau; Philippe - Gandelu N/A FR
  • Duchateau; Philippe - Cerny N/A FR
  • Duchateau; Philippe - Cemy FR
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Cellular Immunotherapy For Repetitive Administration
App 20220233588 - SOURDIVE; David ;   et al.
2022-07-28
Methods for engineering T cells for immunotherapy by using RNA-guided Cas nuclease system
Grant 11,365,430 - Duchateau , et al. June 21, 2
2022-06-21
Chimeric antigen receptors targeting B-cell maturation antigen
Grant 11,312,782 - Kuo , et al. April 26, 2
2022-04-26
Method For The Generation Of Compact Tale-nucleases And Uses Thereof
App 20220010292 - Duchateau; Philippe ;   et al.
2022-01-13
Method to overcome DNA chemical modifications sensitivity of engineered TALE DNA binding domains
Grant 11,220,683 - Duchateau , et al. January 11, 2
2022-01-11
Method for the generation of compact tale-nucleases and uses thereof
Grant 11,198,856 - Duchateau , et al. December 14, 2
2021-12-14
Methods for engineering allogeneic T cell to increase their persistence and/or engraftment into patients
Grant 11,186,824 - Duchateau , et al. November 30, 2
2021-11-30
Tale-protein scaffolds and uses thereof
Grant 11,136,566 - Duchateau , et al. October 5, 2
2021-10-05
Universal Anti-cd22 Chimeric Antigen Receptor Engineered Immune Cells
App 20210161954 - Smith; Julianne ;   et al.
2021-06-03
Anti-CLL1 specific single-chain chimeric antigen receptors (scCARs) for cancer immunotherapy
Grant 11,014,989 - Smith , et al. May 25, 2
2021-05-25
Methods For Engineering T Cells For Immunotherapy By Using Rna-guided Cas Nuclease System
App 20210147868 - DUCHATEAU; Philippe ;   et al.
2021-05-20
Anti-hbv Combination Therapies Involving Specific Endonucleases
App 20210139870 - DUCHATEAU; Philippe
2021-05-13
Engineered Immune Cells Resistant To Tumor Microenvironment
App 20210128613 - DUCHATEAU; Philippe ;   et al.
2021-05-06
Chimeric antigen receptors with integrated controllable functions
Grant 10,988,542 - Juillerat , et al. April 27, 2
2021-04-27
New Universal Chimeric Antigen Receptor T Cells Specific For Cd22
App 20210100839 - Schiffer-Mannioui; Cecile ;   et al.
2021-04-08
Tale-nucleases For Allele-specific Codon Modification And Multiplexing
App 20210017545 - BOYNE; Alex ;   et al.
2021-01-21
Method of engineering drug-specific hypersensitive t-cells for immunotherapy by gene inactivation
Grant 10,894,093 - Valton , et al. January 19, 2
2021-01-19
Targeted Gene Integration Of Crs Inhibitor Genes For Improved Immune Cells Therapy
App 20200407694 - BUSSER; Brian ;   et al.
2020-12-31
Cells For Immunotherapy Engineered For Targeting Antigen Present Both On Immune Cells And Pathological Cells
App 20200407682 - DUCHATEAU; Philippe ;   et al.
2020-12-31
Methods for engineering T cells for immunotherapy by using RNA-guided Cas nuclease system
Grant 10,870,864 - Duchateau , et al. December 22, 2
2020-12-22
New Sequence Specific Reagents Targeting Ccr5 In Primary Hematopoietic Cells
App 20200392459 - CATHOMEN; Toni ;   et al.
2020-12-17
Cells for immunotherapy engineered for targeting antigen present both on immune cells and pathological cells
Grant 10,836,998 - Duchateau , et al. November 17, 2
2020-11-17
Transcription activator-like effector (TALE) fusion protein
Grant 10,815,500 - Juillerat , et al. October 27, 2
2020-10-27
Method of engineering chemotherapy drug resistant T-cells for immunotherapy
Grant 10,813,951 - Valton , et al. October 27, 2
2020-10-27
Method For Improving Production Of Car T Cells
App 20200332004 - BOYNE; Alex ;   et al.
2020-10-22
Methods For Engineering T Cells For Immunotherapy By Using Rna-guided Cas Nuclease System
App 20200277625 - DUCHATEAU; Philippe ;   et al.
2020-09-03
Targeted Gene Integration Of Nk Inhibitors Genes For Improved Immune Cells Therapy
App 20200237823 - BUSSER; Brian ;   et al.
2020-07-30
Targeted Gene Insertion For Improved Immune Cells Therapy
App 20200224163 - BUSSER; Brian ;   et al.
2020-07-16
Methods Of Antigen-dependent Chimeric Antigen Receptor (car) Immune Cell Selection
App 20200216515 - DUCHATEAU; Philippe ;   et al.
2020-07-09
Sequential Gene Editing In Primary Immune Cells
App 20200208174 - CABANIOLS; Jean-Pierre ;   et al.
2020-07-02
Methods For Engineering T Cells For Immunotherapy By Using Rna-guided Cas Nuclease System
App 20200181643 - DUCHATEAU; Philippe ;   et al.
2020-06-11
Protease Based Switch Chimeric Antigen Receptors For Safer Cell Immunotherapy
App 20200140560 - Duchateau; Philippe ;   et al.
2020-05-07
Methods for engineering T cells for immunotherapy by using RNA-guided Cas nuclease system
Grant 10,584,352 - Duchateau , et al.
2020-03-10
Chimeric antigen receptor using antigen recognition domains derived from cartilaginous fish
Grant 10,526,406 - Duchateau , et al. J
2020-01-07
Rare-cutting endonucleases for efficient and specific targeting DNA sequences comprising highly repetitive motives
Grant 10,508,289 - Duchateau , et al. Dec
2019-12-17
Modular base-specific nucleic acid binding domains from burkholderia rhizoxinica proteins
Grant 10,472,396 - Bertonati , et al. Nov
2019-11-12
Method for modulating car-induced immune cells activity
Grant 10,472,613 - Duchateau , et al. Nov
2019-11-12
Method To Overcome Dna Chemical Modifications Sensitivity Of Engineered Tale Dna Binding Domains
App 20190338273 - DUCHATEAU; Philippe ;   et al.
2019-11-07
Cell Death Inducing Chimeric Antigen Receptors
App 20190338015 - JUILLERAT; Alexandre ;   et al.
2019-11-07
A Method Of Engineering Prodrug-specific Hypersensitive T-cells For Immunotherapy By Gene Expression
App 20190328783 - VALTON; Julien ;   et al.
2019-10-31
Tale-protein Scaffolds And Uses Thereof
App 20190316100 - Duchateau; Philippe ;   et al.
2019-10-17
Stably Enginereed Proteasome Inhibitor Resistant Immune Cells For Immunotherapy
App 20190290694 - GAUTRON; Anne-Sophie ;   et al.
2019-09-26
Methods for modulating TAL specificity
Grant 10,378,007 - Juillerat , et al. A
2019-08-13
Chimeric Antigen Receptors Targeting B-cell Maturation Antigen
App 20190241669 - KUO; Tracy Chia-Chien ;   et al.
2019-08-08
Method to overcome DNA chemical modifications sensitivity of engineered tale DNA binding domains
Grant 10,301,614 - Duchateau , et al.
2019-05-28
A Method Of Engineering Drug-specific Hypersensitive T-cells For Immunotherapy By Gene Inactivation
App 20190151478 - VALTON; Julien ;   et al.
2019-05-23
Chimeric antigen receptors targeting B-cell maturation antigen
Grant 10,294,304 - Kuo , et al.
2019-05-21
Method of engineering multi-input signal sensitive T cell for immunotherapy
Grant 10,239,948 - Juillerat , et al.
2019-03-26
Method for in situ inhibition of regulatory T cells
Grant 10,196,608 - Poirot , et al. Fe
2019-02-05
Micelle Based System Nuclease Encapsulation For In-vivo Gene Editing
App 20190032088 - DUCHATEAU; Philippe ;   et al.
2019-01-31
Primary Hematopoietic Cells Genetically Engineered By Slow Release Of Nucleic Acids Using Nanoparticles
App 20190024065 - DELACOTE; Fabien ;   et al.
2019-01-24
Method For Generating T-cells Compatible For Allogenic Transplantation
App 20190010514 - POIROT; Laurent ;   et al.
2019-01-10
Method For Producing Precise Dna Cleavage Using Cas9 Nickase Activity
App 20180327761 - DUCHATEAU; Philippe ;   et al.
2018-11-15
Methods For Engineering Allogeneic T Cell To Increase Their Persistence And/or Engraftment Into Patients
App 20180291343 - DUCHATEAU; Philippe ;   et al.
2018-10-11
Modified diatoms for biofuel production
Grant 10,087,453 - Duchateau , et al. October 2, 2
2018-10-02
Chimeric Antigen Receptors With Integrated Controllable Functions
App 20180237533 - JUILLERAT; Alexandre ;   et al.
2018-08-23
Methods For Engineering T Cells For Immunotherapy By Using Rna-guided Cas Nuclease System
App 20180237798 - DUCHATEAU; Philippe ;   et al.
2018-08-23
Method For In Situ Inhibition Of Regulatory T Cells
App 20180208896 - POIROT; Laurent ;   et al.
2018-07-26
Cells For Immunotherapy Engineered For Targeting Antigen Present Both On Immune Cells And Pathological Cells
App 20180201901 - DUCHATEAU; Philippe ;   et al.
2018-07-19
Methods For Improving Functionality In Nk Cell By Gene Inactivation Using Specific Endonuclease
App 20180171298 - DUCHATEAU; Philippe ;   et al.
2018-06-21
T Cell Receptor Knock Out Engineered Immune Cells, Endowed With Chimeric Antigen Receptors Binding To Cd123 For The Treatment Of Relapsed/refractory Acute Myeloid Lymphoma Or Blastic Plasmacytoid Dendritic Cell Neoplasm
App 20180051089 - GALETTO; Roman ;   et al.
2018-02-22
Methods for engineering T cells for immunotherapy by using RNA-guided CAS nuclease system
Grant 9,890,393 - Duchateau , et al. February 13, 2
2018-02-13
Anti-cll1 Specific Single-chain Chimeric Antigen Receptors (sccars) For Cancer Immunotherapy
App 20180009895 - SMITH; Julianne ;   et al.
2018-01-11
Anti-hsp70 Specific Chimeric Antigen Receptors (cars) For Cancer Immunotherapy
App 20180000914 - VALTON; Julien ;   et al.
2018-01-04
mAb-DRIVEN CHIMERIC ANTIGEN RECEPTOR SYSTEMS FOR SORTING/DEPLETING ENGINEERED IMMUNE CELLS
App 20180002435 - SASU; Barbara Johnson ;   et al.
2018-01-04
Cll1-specific Multi-chain Chimeric Antigen Receptor
App 20180002427 - SMITH; Julianne ;   et al.
2018-01-04
Methods for engineering T cells for immunotherapy by using RNA-guided CAS nuclease system
Grant 9,855,297 - Duchateau , et al. January 2, 2
2018-01-02
INHIBITORY CHIMERIC ANTIGEN RECEPTOR (iCAR OR N-CAR) EXPRESSING NON-T CELL TRANSDUCTION DOMAIN
App 20170296623 - JUILLERAT; Alexandre ;   et al.
2017-10-19
Method For Modulating Car-induced Immune Cells Activity
App 20170292118 - DUCHATEAU; Philippe ;   et al.
2017-10-12
Engineering Mammalian Genome Using Dna-guided Argonaute Interference Systems (dais)
App 20170198306 - Valton; Julien ;   et al.
2017-07-13
Method Of Engineering Multi-input Signal Sensitive T Cell For Immunotherapy
App 20170073423 - JUILLERAT; Alexandre ;   et al.
2017-03-16
Method For In Situ Inhibition Of Regulatory T Cells
App 20170067022 - Poirot; Laurent ;   et al.
2017-03-09
Method For Generating T-cells Compatible For Allogenic Transplantation
App 20170016025 - POIROT; Laurent ;   et al.
2017-01-19
Method Of Engineering Chemotherapy Drug Resistant T-cells For Immunotherapy
App 20160361359 - VALTON; Julien ;   et al.
2016-12-15
Methods And Kits For Detecting Nucleic Acid Sequences Of Interest Using Dna-binding Protein Domain
App 20160355875 - VALTON; Julien ;   et al.
2016-12-08
Chimeric Antigen Receptor Using Antigen Recognition Domains Derived From Cartilaginous Fish
App 20160333094 - DUCHATEAU; Philippe ;   et al.
2016-11-17
New Method Of Selection Of Algal-transformed Cells Using Nuclease
App 20160312233 - DUCHATEAU; Philippe ;   et al.
2016-10-27
Chimeric Antigen Receptors Targeting B-cell Maturation Antigen
App 20160297884 - KUO; TRACY CHIA-CHIEN ;   et al.
2016-10-13
Method For The Generation Of Compact Tale-nucleases And Uses Thereof
App 20160298098 - Duchateau; Philippe ;   et al.
2016-10-13
Use Of Meganucelases For Inducing Homologous Recombination Ex Vivo And In Toto In Vertebrate Somatic Tissues And Application Thereof
App 20160273003 - DUCHATEAU; Philippe ;   et al.
2016-09-22
Method For Targeted Modification Of Algae Genomes
App 20160272980 - DUCHATEAU; Philippe ;   et al.
2016-09-22
Methods For Engineering T Cells For Immunotherapy By Using Rna-guided Cas Nuclease System
App 20160272999 - DUCHATEAU; Philippe ;   et al.
2016-09-22
Design Of Rare-cutting Endonucleases For Efficient And Specific Targeting Dna Sequences Comprising Highly Repetitive Motives
App 20160273002 - DUCHATEAU; Philippe ;   et al.
2016-09-22
Methods For Engineering T Cells For Immunotherapy By Using Rna-guided Cas Nuclease System
App 20160184362 - DUCHATEAU; Philippe ;   et al.
2016-06-30
Improved Polynucleotide Sequences Encoding Tale Repeats
App 20160138047 - DUCHATEAU; Philippe ;   et al.
2016-05-19
Modified Diatoms For Biofuel Production
App 20160130599 - DUCHATEAU; Philippe ;   et al.
2016-05-12
A Method For Producing Precise Dna Cleavage Using Cas9 Nickase Activity
App 20160122774 - DUCHATEAU; Philippe ;   et al.
2016-05-05
Method for the generation of compact TALE-nucleases and uses thereof
Grant 9,315,788 - Duchateau , et al. April 19, 2
2016-04-19
New Compact Scaffold Of Cas9 In The Type Ii Crispr System
App 20160102324 - DUCHATEAU; Philippe ;   et al.
2016-04-14
New Modular Base-specific Nucleic Acid Binding Domains From Burkholderia Rhizoxinica Proteins
App 20150225465 - BERTONATI; Claudia ;   et al.
2015-08-13
Methods For Modulating Tal Specificity
App 20150218230 - Juillerat; Alexandre ;   et al.
2015-08-06
Transcription Activator-Like Effector (TALE) Fusion Protein
App 20150203871 - Juillerat; Alexandre ;   et al.
2015-07-23
Method for modulating the efficiency of double-strand break-induced mutagenesis
Grant 9,044,492 - Delacote , et al. June 2, 2
2015-06-02
New Repeat Variable Diresidues For Targeting Nucleotides
App 20150067900 - Duchateau; Philippe ;   et al.
2015-03-05
Method To Overcome Dna Chemical Modifications Sensitivity Of Engineered Tale Dna Binding Domains
App 20150037809 - Duchateau; Philippe ;   et al.
2015-02-05
Method for modulating double-strand break-induced homologous recombination
Grant 8,906,607 - Duchateau , et al. December 9, 2
2014-12-09
High Throughput Method For Assembly And Cloning Polynucleotides Comprising Highly Similar Polynucleotidic Modules
App 20140309145 - Valton; Julien ;   et al.
2014-10-16
Modular Base-specific Nucleic Acid Binding Domains From Burkholderia Rhizoxinica Proteins
App 20140230083 - Bertonati; Claudia ;   et al.
2014-08-14
I-CreI meganuclease variants with modified specificity, method of preparation and uses thereof
Grant 8,715,992 - Duchateau , et al. May 6, 2
2014-05-06
New Tale-protein Scaffolds And Uses Thereof
App 20140115726 - Duchateau; Philippe ;   et al.
2014-04-24
Method For Increasing The Efficiency Of Double-strand Break-induced Mutagenesis
App 20130337454 - Duchateau; Philippe ;   et al.
2013-12-19
Use of meganucleases for inducing homologous recombination ex vivo and in toto in vertebrate somatic tissues and application thereof
Grant 8,530,214 - Arnould , et al. September 10, 2
2013-09-10
Use Of Meganucleases For Inducing Homologous Recombination Ex Vivo And In Toto In Vertebrate Somatic Tissues And Application Thereof
App 20130203840 - ARNOULD; Sylvain ;   et al.
2013-08-08
Method For Improving Cleavage Of Dna By Endonuclease Sensitive To Methylation
App 20130196320 - Duchateau; Philippe ;   et al.
2013-08-01
Method For Modulating Double-strand Break-induced Homologous Recombination
App 20130190385 - Duchateau; Philippe ;   et al.
2013-07-25
I-crei Variants With New Specificity And Methods Of Their Generation
App 20130149786 - Duchateau; Philippe ;   et al.
2013-06-13
Method For The Generation Of Compact Tale-nucleases And Uses Thereof
App 20130117869 - DUCHATEAU; PHILIPPE ;   et al.
2013-05-09
Use Of Meganucleases For Inducing Homologous Recombination Ex Vivo And In Toto In Vertebrate Somatic Tissues And Application Thereof
App 20120288942 - Arnould; Sylvain ;   et al.
2012-11-15
Use Of Meganucleases For Inducing Homologous Recombination Ex Vivo And In Toto In Vertebrate Somatic Tissues And Application Thereof
App 20120288943 - Arnould; Sylvain ;   et al.
2012-11-15
I-crei Meganuclease Variants With Modified Specificity, Method Of Preparation And Uses Thereof
App 20120258537 - DUCHATEAU; Philippe ;   et al.
2012-10-11
Method For Modulating The Efficiency Of Double-strand Break-induced Mutagenesis
App 20120244131 - Delacote; Fabien ;   et al.
2012-09-27
Custom-made Meganuclease And Use Thereof
App 20120159659 - Arnould; Sylvain ;   et al.
2012-06-21
Use Of Meganucleases For Inducing Homologous Recombination Ex Vivo And In Toto In Vertebrate Somatic Tissues And Application Thereof
App 20110287513 - Arnould; Sylvain ;   et al.
2011-11-24
Novel Method To Generate Meganucleases With Altered Characteristics
App 20110207199 - Paques; Frederic ;   et al.
2011-08-25
Chimeric Meganuclease Enzymes And Uses Thereof
App 20110173710 - Grizot; Sylvestre ;   et al.
2011-07-14
Heterodimeric Meganucleases and Use Thereof
App 20110158974 - Duchateau; Philippe ;   et al.
2011-06-30
Use Of Meganucleases For Inducing Homologous Recombination Ex Vivo And In Toto In Vertebrate Somatic Tissues And Application Thereof
App 20110151539 - Arnould; Sylvain ;   et al.
2011-06-23
I-crei Meganuclease Variants With Modified Specificity, Method Of Preparation And Uses Thereof
App 20110072527 - DUCHATEAU; Philippe ;   et al.
2011-03-24
I-CreI meganuclease variants with modified specificity, method of preparation and uses thereof
Grant 7,897,372 - Duchateau , et al. March 1, 2
2011-03-01
Use of meganucleases for inducing homologous recombination ex vivo and in toto in vertebrate somatic tissues and application thereof
Grant 7,842,489 - Arnould , et al. November 30, 2
2010-11-30
Use Of Meganucleases For Inducing Homologous Recombination Ex Vivo And In Toto In Vertebrate Somatic Tissues And Application Thereof
App 20100144012 - ARNOULD; Sylvain ;   et al.
2010-06-10
I-crei Meganuclease Variants With Modified Specificity, Method Of Preparation And Uses Thereof
App 20100021448 - Duchateau; Philippe ;   et al.
2010-01-28
Custom-made meganuclease and use thereof
App 20060206949 - Arnould; Sylvain ;   et al.
2006-09-14
Use of meganucleases for inducing homologous recombination ex vivo and in toto in vertebrate somatic tissues and application thereof
App 20060153826 - Arnould; Sylvain ;   et al.
2006-07-13

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed